Sanofi Pulls Allevia 'Non-Drowsy' Claim Following MHRA Probe
Sanofi's claim in a TV ad that its Allevia hay fever tablets were non drowsy contradicted the drug's summary of product characteristics, found an investigation by the UK's Medicines and Healthcare products Regulatory Agency.
You may also be interested in...
As Sanofi reports Consumer Healthcare second-quarter sales up by 9%, the company is hopeful it can progress its plan to switch erectile dysfunction drug Cialis in the US following a constructive meeting with the FDA.
Sanofi has switched its Allevia hay fever tablets (fexofenadine hydrochloride) in the UK, from prescription-only to general sales list status.
Sanofi's decision to promote its Phenergan sleep-aid through a social media influencer - even one with a relatively small following - was tantamount to a celebrity endorsement, says the UK's advertising regulator.